Inhibiting CXCR4 Attenuates TOX-Programmed Exhausted Phenotype of CD8+ T cells via Regulating JAK2/STAT3 Pathway
ChIP-seq / ATAC-seq (genome binding and open chromatin) · mouse · 48 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Mus musculus (mouse)
- Samples
- 48 samples: 12 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- CXCR4 orchestrates the TOX-programmed exhausted phenotype of CD8(+) T cells via JAK2/STAT3 pathwayCell genomics · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE255182_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1073888 and SRA study SRP497842. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 36 samples.
How we read this: 12 replicated groups read from 48 sample titles; they account for 36 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8065412 Jurkat_control_input
- GSM8065413 Jurkat_plerixafor_input
- GSM8065414 Jurkat_control_tox_1 Jurkat_control_tox
- GSM8065415 Jurkat_control_tox_2 Jurkat_control_tox
- GSM8065416 Jurkat_plerixafor_tox_1 Jurkat_plerixafor_tox
- GSM8065417 Jurkat_plerixafor_tox_2 Jurkat_plerixafor_tox
- GSM8065418 Jurkat_control_pstat3_1 Jurkat_control_pstat3
- GSM8065419 Jurkat_control_pstat3_2 Jurkat_control_pstat3
- GSM8065420 Jurkat_plerixafor_pstat3_1 Jurkat_plerixafor_pstat3
- GSM8065421 Jurkat_plerixafor_pstat3_2 Jurkat_plerixafor_pstat3
- GSM8065422 Mouse T cell_control_input
- GSM8065423 Mouse T cell_plerixafor_input
- GSM8065424 Mouse T cell_control_tox_1 Mouse T cell_control_tox
- GSM8065425 Mouse T cell_control_tox_2 Mouse T cell_control_tox
- GSM8065426 Mouse T cell_plerixafor_tox_1 Mouse T cell_plerixafor…
- GSM8065427 Mouse T cell_plerixafor_tox_2 Mouse T cell_plerixafor…
- GSM8065428 Mouse T cell_control_pstat3_1 Mouse T cell_control_ps…
- GSM8065429 Mouse T cell_control_pstat3_2 Mouse T cell_control_ps…
- GSM8065430 Mouse T cell_plerixafor_pstat3_1 Mouse T cell_plerixafor…
- GSM8065431 Mouse T cell_plerixafor_pstat3_2 Mouse T cell_plerixafor…
- GSM8065548 Solution, replication1 Solution, replication
- GSM8065549 Solution, replication2 Solution, replication
- GSM8065550 Solution, replication3 Solution, replication
- GSM8065551 Solution, replication4 Solution, replication
- GSM8065552 Solution, replication5 Solution, replication
- GSM8065553 Plerixafor, replication1 Plerixafor, replication
- GSM8065554 Plerixafor, replication2 Plerixafor, replication
- GSM8065555 Plerixafor, replication3 Plerixafor, replication
- GSM8065556 Plerixafor, replication4 Plerixafor, replication
- GSM8065557 Plerixafor, replication5 Plerixafor, replication
- GSM8065558 anti-PD-1, replication1 anti-PD-1, replication
- GSM8065559 anti-PD-1, replication2 anti-PD-1, replication
- GSM8065560 anti-PD-1, replication3 anti-PD-1, replication
- GSM8065561 anti-PD-1, replication4 anti-PD-1, replication
- GSM8065562 anti-PD-1, replication5 anti-PD-1, replication
- GSM8065563 Combination, replication1 Combination, replication
- GSM8065564 Combination, replication2 Combination, replication
- GSM8065565 Combination, replication3 Combination, replication
- GSM8065566 Combination, replication4 Combination, replication
- GSM8065567 Combination, replication5 Combination, replication
+ 8 more — browse all 48 samples with per-sample file links →
- GSE296112 Augment proteasome inhibitor efficacy activates CD8+ T cell-mediated antitumor immunity in breast cancer 27 samples shares cd8
- GSE244433 Human single cell RNA-sequencing reveals a targetable CD8+ exhausted T cell population that maintains murine low-grade glioma growth 16 samples shares cd8
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.